EDGAR Filing Documents for 9999999995-23-002501

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-23-002501

Accepted

2023-08-28 00:15:15

Documents

Effectiveness Date

2023-08-25

Registration Form

S-3

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	595
	Complete submission text file	9999999995-23-002501.txt		1744

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)